The following is a summary of “Risk Stratification for Postoperative Opioid Induced Respiratory Depression: A Retrospective Case-Control Analysis of Existing Validated Tools” published in the April ...

After a family tragedy, a push for new opioid laws in Texas 07:32. Debbie Allen visits her husband's grave each month to ...

Agents that target NaV1.8, a voltage-gated sodium channel, are showing promise. The FDA approved one of them, Journavx ...

Olutayo Nathanael Farinde, a synthetic organic and medicinal researcher at the University of Toledo, shares his bold efforts ...

Kootenai County Fire and Rescue is in charge of the statewide program to distribute free Narcan, In the last seven months, it ...

Experts are sounding the alarm about increased use of kratom and about highly concentrated products containing 7-OH, a more ...

Tianeptine, known as "gas station heroin," prompts FDA warning as the unregulated substance causes severe health risks ...

Beijing Tide Pharmaceutical Co., Ltd., a subsidiary of Sino Biopharmaceutical Limited (1177.HK), has achieved a milestone in developing its first-in-class analgesic drug (research code: TRD205), a ...

His bill gives an example of what it should look like: "CAUTION: Opioid. Risk of Addiction, Respiratory Depression, and Overdose." “Information, to me, is one of the best forms of government.

By selectively blocking this pathway, TRD205 suppresses pain signaling at its source without engaging the central nervous ...

thereby avoiding opioid-related risks such as addiction and respiratory depression. The drug has secured clinical trial approvals from both the U.S. FDA and China's NMPA, with Phase I trials in ...